ENSYSCE BIOSCIENCES INC (ENSC:NASDAQ)
$0.3 -0.0075 (-2.439%)
Analysed ENSYSCE BIOSCIENCES INC (ENSC:NASDAQ) News Sources
Ensysce Biosciences Announces First Peer-Reviewed Clinical Publication Demonstrating Oral Overdose Protection with MPAR(R) Technology
03-03-2026
yahoo.com
Ensysce Biosciences Initiates Live "Ask Me Anything" (AMA) Session Highlighting Growth and Future Plans
04-03-2026
yahoo.com
Ensysce Biosciences Reports Fourth Quarter and Full Year 2025 Financial Results
30-03-2026
yahoo.com
ENSC Making Great Strides Toward Commercialization
31-03-2026
yahoo.com
Ensysce Biosciences Secures Second Financing From 2025 Agreement to Advance Breakthrough Pain Programs
07-04-2026
yahoo.com
Ensysce Biosciences Secures IRB Approval of Final Phase of PF614-MPAR-102 Clinical Study
16-04-2026
yahoo.com
Ensysce Biosciences CEO Presents at Inaugural Clinical Pain Symposium in Amsterdam
08-05-2026
yahoo.com
Ensysce Biosciences Announces Expansion of Patent Protection for Groundbreaking MPAR(R) Overdose Protection Technology
12-05-2026
yahoo.com
Ensysce Biosciences Reports First Quarter 2026 Financial Results
15-05-2026
yahoo.com
ENSC Advancing Testing and Expanding Potential
18-05-2026
yahoo.com
What is the current price of ENSYSCE BIOSCIENCES INC (ENSC:NASDAQ)?
The current price of ENSYSCE BIOSCIENCES INC (ENSC:NASDAQ) is $0.3.
ENSYSCE BIOSCIENCES INC (ENSC:NASDAQ) absolute price change since previous trading day?
The absolute price change of ENSYSCE BIOSCIENCES INC (ENSC:NASDAQ) since the previous trading day is $-0.0075.
ENSYSCE BIOSCIENCES INC (ENSC:NASDAQ) percentage price change since previous trading day?
The percentage price change of ENSYSCE BIOSCIENCES INC (ENSC:NASDAQ) since the previous trading day is -2.439%.
What is the most recent average sentiment score for ENSYSCE BIOSCIENCES INC (ENSC:NASDAQ)?
The most recent average sentiment score for ENSYSCE BIOSCIENCES INC (ENSC:NASDAQ) is 77 out of 100.
What is the most recent average sentiment for ENSYSCE BIOSCIENCES INC (ENSC:NASDAQ)?
The most recent sentiment for ENSYSCE BIOSCIENCES INC (ENSC:NASDAQ) is .
SEC-8K** Filing Available For ENSYSCE BIOSCIENCES INC (ENSC:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.